NEJM Evidence — A New Journal in the NEJM Group Family

Chana A. Sacks, M.D., M.P.H., C. Corey Hardin, M.D., Ph.D., Sharon-Lise Normand, Ph.D., M.Sc., Siri Kadire, M.D., Kate Takvorian, M.D., M.P.H., Neil Galloway, Rebekah Linga, Patrick Hannon, Jeffrey Drazen, M.D., and Eric Rubin, M.D., Ph.D.
Sharon-Lise Normand
New England Journal of Medicine
https://www.nejm.org/doi/10.1056/NEJMe2118588?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed

Problems with evidence assessment in COVID-19 health policy impact evaluation: a systematic review of study design and evidence strength

Noah A Haber, Emma Clarke-Deelder, Avi Feller, Emily R Smith, Joshua A Salomon, Benjamin MacCormack-Gelles, Elizabeth M Stone, Clara Bolster-Foucault, Jamie R Daw, Laura Anne Hatfield, Carrie E Fry, Christopher B Boyer, Eli Ben-Michael, Caroline M Joyce, Beth S Linas, Ian Schmid, Eric H Au, Sarah E Wieten, Brooke Jarrett, Cathrine Axfors, Beth Ann Griffin, Alyssa Bilinski, Elizabeth A Stuart
BMJ Open
https://bmjopen.bmj.com/content/12/1/e053820.abstract

Health Care Utilization and Spending in Medicare Advantage vs Traditional Medicare: A Difference-in-Difference Analysis

Aaron L. Schwartz, Khalil Zlaoui, Robin P. Foreman, Troyen A. Brennan, and Joseph P. Newhouse
Joseph P. Newhouse
JAMA Health Forum
18. Aaron L. Schwartz, Khalil Zlaoui, Robin P. Foreman, Troyen A. Brennan, and Joseph P. Newhouse, “Health Care Utilization and Spending in Medicare Advantage vs Traditional Medicare: A Difference-in-Difference Analysis,” JAMA Health Forum, 2021, 2(12):e214001.